Literature DB >> 34089418

Anti-glial fibrillary acidic protein antibodies as a cause of reversible splenial lesion syndrome (RESLES): a case report.

Kundian Guo1, Xiaohui Lai1, Yue Liu1, Dong Zhou1, Zhen Hong2,3.   

Abstract

Entities:  

Year:  2021        PMID： 34089418     DOI： 10.1007/s10072-021-05376-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  10 in total

1.  Mild encephalitis/encephalopathy with a reversible splenial, white matter, putaminal, and thalamic lesions following anti-Yo rhombencephalitis.

Authors:  Dimitri Renard; Guillaume Taieb; Caroline Briere; Christian Bengler; Giovanni Castelnovo
Journal:  Acta Neurol Belg       Date:  2012-05-11       Impact factor: 2.396

2.  N-methyl-d-aspartate receptor encephalitis with a reversible splenial lesion.

Authors:  J A Kaminski; H Prüss
Journal:  Eur J Neurol       Date:  2019-06       Impact factor: 6.089

3.  Severe anti-GFAP meningo-encephalomyelitis following viral infection.

Authors:  Nahéma Issa; Clément Martin; Cécile Dulau; Fabrice Camou
Journal:  Mult Scler Relat Disord       Date:  2020-08-19       Impact factor: 4.339

4.  Mild Encephalitis/Encephalopathy with reversible splenial lesion syndrome: An unusual presentation of anti-GFAP astrocytopathy.

Authors:  Valentin Oger; Chloé Bost; Lucie Salah; Elise Yazbeck; Hélène Maurey; Céline Bellesme; Caroline Sevin; Catherine Adamsbaum; Pascale Chrétien; Marie Benaiteau; Jérôme Honnorat; Kumaran Deiva
Journal:  Eur J Paediatr Neurol       Date:  2020-03-18       Impact factor: 3.140

Review 5.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion.

Authors:  H Tada; J Takanashi; A J Barkovich; H Oba; M Maeda; H Tsukahara; M Suzuki; T Yamamoto; T Shimono; T Ichiyama; T Taoka; O Sohma; H Yoshikawa; Y Kohno
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  Association of reversible splenial lesion syndrome (RESLES) with Anti-VGKC autoantibody syndrome: a case report.

Authors:  Thomas R Gilder; Jason S Hawley; Brett J Theeler
Journal:  Neurol Sci       Date:  2016-01-07       Impact factor: 3.307

Review 7.  Reversible splenial lesion syndrome (RESLES): what's in a name?

Authors:  Juan Carlos Garcia-Monco; Ines Escalza Cortina; Eva Ferreira; Amaia Martínez; Lara Ruiz; Alberto Cabrera; Marian Gomez Beldarrain
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

8.  Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.

Authors:  Yuanzhao Zhu; Junjun Zheng; Ling Zhang; Zhenguo Zeng; Min Zhu; Xiaobin Li; Xiaoliang Lou; Hui Wan; Daojun Hong
Journal:  BMC Neurol       Date:  2016-04-18       Impact factor: 2.474

Review 9.  Reversible splenial lesion syndrome (RESLES) coinciding with cerebral venous thrombosis: a report of two cases.

Authors:  Jingyi Liu; Dacheng Liu; Bo Yang; Jing Yan; Yuehua Pu; Jing Zhang; Miao Wen; Zhonghua Yang; Liping Liu
Journal:  Ther Adv Neurol Disord       Date:  2017-08-28       Impact factor: 6.570

Review 10.  Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature.

Authors:  Fulan Shan; Youming Long; Wei Qiu
Journal:  Front Immunol       Date:  2018-12-05       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.